Document:

exv10w13

Exhibit 10.13

 

 

HUMAN GENOME SCIENCES, INC.,

as Lessee

and

MANUFACTURERS AND TRADERS TRUST COMPANY,

as Bank

 

REIMBURSEMENT AGREEMENT

 

$17,500,000

Maryland Economic Development Corporation

Taxable Variable Rate Demand/Fixed Rate Revenue Bonds

(Human Genome Sciences, Inc. Facility)

Series 1999 A and B

 

Dated as of December 1, 2009

 

      

 

 

 

 

TABLE OF CONTENTS

     (This Table of Contents is not a part of the Reimbursement Agreement and is only for
convenience of reference.)

	 	 	 	 	 
	SECTION	 	PAGE
	RECITALS

	 	 	1	 
	AGREEMENTS

	 	 	2	 

ARTICLE I

DEFINITIONS

	 	 	 	 	 
	Section 1.1 Definitions

	 	 	2	 
	Section 1.2 Rules of Construction

	 	 	9	 

ARTICLE II

EFFECTIVE DATE OF REIMBURSEMENT

AGREEMENT; DURATION OF TERM

	 	 	 	 	 
	Section 2.1 Effective Date of Reimbursement Agreement; Duration of Term

	 	 	9	 

ARTICLE III

PAYMENT PROVISIONS

	 	 	 	 	 
	Section 3.1 Reimbursement and Other Payments

	 	 	10	 
	Section 3.2 Payments due Upon Expiration of Letter of Credit

	 	 	12	 
	Section 3.3 Late Payments

	 	 	13	 
	Section 3.4 Increased Costs Due to Change in Law

	 	 	13	 
	Section 3.5 Computation

	 	 	14	 
	Section 3.6 Payment Procedure

	 	 	14	 
	Section 3.7 Business Days

	 	 	14	 

ARTICLE IV

UNCONDITIONAL OBLIGATIONS

	 	 	 	 	 
	Section 4.1 Obligations Absolute

	 	 	14	 

ARTICLE V

REPRESENTATIONS AND WARRANTIES

	 	 	 	 	 
	Section 5.1 Representations, Warranties and Undertakings

	 	 	15	 

ARTICLE VI

AFFIRMATIVE COVENANTS OF LESSEE

	 	 	 	 	 
	Section 6.1 Affirmative Covenants of Lessee

	 	 	16	 

-i-

 

ARTICLE VII

INDEMNIFICATION

	 	 	 	 	 
	Section 7.1 Indemnification of Bank

	 	 	17	 
	Section 7.2 Indemnification Under Letters of Credit and Letter of Credit Agreements

	 	 	18	 

ARTICLE VIII

EVENTS OF DEFAULT AND REMEDIES

	 	 	 	 	 
	Section 8.1 Events of Default Defined

	 	 	18	 
	Section 8.2 Remedies on Default

	 	 	20	 
	Section 8.3 No Remedy Exclusive

	 	 	21	 
	Section 8.4 Agreement to Pay Attorneys’ Fees and Expenses
	 	 	22	 
	Section 8.5 Waiver of Event of Default; No Additional Waiver Implied by One Waiver

	 	 	22	 

ARTICLE IX

MISCELLANEOUS

	 	 	 	 	 
	Section 9.1 Notices

	 	 	22	 
	Section 9.2 [Intentionally Omitted]

	 	 	23	 
	Section 9.3 [Intentionally Omitted]

	 	 	23	 
	Section 9.4 Binding Effect

	 	 	23	 
	Section 9.5 Illegality; Severability

	 	 	23	 
	Section 9.6 Assignment

	 	 	24	 
	Section 9.7 Consent to Jurisdiction; Service of Process; Waiver of Jury Trial

	 	 	24	 
	Section 9.8 Further Assurances and Corrective Instruments

	 	 	24	 
	Section 9.9 Right to Perform; Advances by Bank

	 	 	25	 
	Section 9.10 Amendments, Changes and Modifications

	 	 	25	 
	Section 9.11 Execution of Counterparts

	 	 	25	 
	Section 9.12 Law Governing Construction of Agreement

	 	 	25	 
	Section 9.13 Effective Date

	 	 	25	 
	Section 9.14 Conflicting Agreements

	 	 	25	 
	Section 9.15 Set-off

	 	 	25	 

-ii-

 

REIMBURSEMENT AGREEMENT

     THIS REIMBURSEMENT AGREEMENT is dated as of December 1, 2009 and is made by and between HUMAN
GENOME SCIENCES, INC., a Delaware corporation (the “Lessee”), and MANUFACTURERS AND TRADERS TRUST
COMPANY, a New York banking corporation (the “Bank”).

RECITALS

     Certain of the terms and words used in these Recitals are defined in Section 1.1 of this
Reimbursement Agreement.

     Pursuant to and in accordance with the Act, the Issuer has previously issued and sold Bonds in
the original aggregate principal amount of $17,500,000 for the sole and exclusive purpose of
financing a portion of the costs of the Facility. The Issuer leases the Facility to the Lessee
pursuant to the Facility Lease.

     The Bonds were issued pursuant to the Indenture.

     In order to enhance the marketability of the Series A Bonds, at the request of the Issuer and
the Lessee, Allfirst Bank, a Maryland state-chartered commercial bank (“Allfirst”), predecessor in
interest to the Bank, issued to the Trustee the Series A Bonds Letter of Credit to provide payment
for, and to secure the payment of the principal of, and interest on, and the purchase price of the
Series A Bonds. Allfirst issued the Series A Bonds Letter of Credit pursuant to a Letter of Credit
Agreement dated as of December 1, 1999, by and between Allfirst and the Issuer (the “Allfirst
Letter of Credit Agreement”).

     In order to enhance the marketability of the Series B Bonds, at the request of the Issuer and
the Lessee, First Union National Bank (“First Union”) issued to the Trustee First Union’s
irrevocable, transferable direct-pay letter of credit (the “First Union Letter of Credit”) to
provide payment for, and to secure the payment of the principal of, and interest on, and the
purchase price of the Series B Bonds. First Union issued the First Union Letter of Credit pursuant
to a Letter of Credit Agreement dated as of December 1, 1999, by and between First Union and the
Issuer.

     The Series A Bonds Letter of Credit and the First Union Letter of Credit each expire on
December 15, 2009.

     At the request of the Issuer and the Lessee, the Bank, as successor in interest to Allfirst,
has agreed to extend the Series A Bonds Letter of Credit, and, in connection therewith, the Issuer
and the Bank have entered into the Series A Bonds Letter of Credit Agreement, which amends and
restates the Allfirst Letter of Credit Agreement in its entirety.

     In addition, in substitution for the First Union Letter of Credit, at the request of the
Issuer and the Lessee, the Bank has agreed to issue the Series B Bonds Letter of Credit to provide
payment for, and to secure the payment of the principal of, and interest on, and the purchase price
of the Series B Bonds, and, in connection therewith, the Issuer and the Bank have entered into the
Series B Bonds Letter of Credit Agreement.

1

 

     As a condition to the Bank’s extension of the Series A Bonds Letter of Credit and issuance of
the Series B Bonds Letter of Credit, the Bank has required that the Lessee enter into this
Reimbursement Agreement for the benefit of the Bank.

AGREEMENTS

     NOW, THEREFORE, in consideration of the premises, the respective representations, covenants
and agreements hereinafter contained, and other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the parties hereto agree as follows:

ARTICLE I

DEFINITIONS

     Section 1.1 Definitions. Certain terms used in this Reimbursement Agreement are
defined in this Section or are defined by reference to one of the Bond Documents or one of the
other Letter of Credit Documents; and, when and if used herein, such terms shall have the meanings
given to them by the language employed in this Section defining such terms or by the language
employed in such Bond Document or other Letter of Credit Document defining such terms, unless the
context clearly indicates otherwise.

     “Acceleration Drawing” has the meaning given to that term in the Letters of Credit.

     “Act” means Section 10-101, et. seq. of the Economic Development Article of the Annotated Code
of Maryland, as amended, and all future laws supplemental thereto or amendatory thereof.

     “Act of Bankruptcy” means the filing of a petition in bankruptcy under the Bankruptcy Code, or
the commencement of a proceeding under any other applicable law concerning insolvency,
reorganization or bankruptcy.

     “Additional Improvements” means the 43,000 square-foot (approximate) addition to the process
development and manufacturing plant located on the Land.

     “Administration Expenses” means compensation, indemnities and reimbursement of fees, expenses
and advances payable to the Issuer, the Trustee, the Remarketing Agent, the Paying Agent and the
Registrar, all as described in Section 7.10 of the Indenture.

     “Assignment of Leases” means the Assignment, Subordination and Non-Disturbance Agreement of
even date herewith executed by and among the Issuer, the Bank and the Lessee, together with any and
all Supplements thereto.

     “Bank” means Manufacturers and Traders Trust Company, a New York banking corporation, its
successors and assigns.

     “Bankruptcy Code” means the United States Bankruptcy Code, 11 U.S.C. §§ 101 et seq., and all
future acts supplemental thereto or amendatory thereof.

2

 

     “Bond Documents” means and includes (without limitation) the Bonds, the Indenture, the
Placement and Remarketing Agreement and any and all other documents which the Issuer or any other
party or parties or their representatives, have executed and delivered, or may hereafter execute
and deliver, to evidence or secure the Issuer’s Bond Obligations or any part thereof, or in
connection therewith, together with any and all Supplements thereto.

     “Bond Fund” means the Bond Fund created in Section 5.1 of the Indenture.

     “Bond Payment Date” means any Interest Payment Date or any Sinking Fund Installment Date and
any other date on which the principal of, premium (if any) on or interest on the Bonds is to be
paid to the Owners thereof (whether at maturity thereof, or by acceleration of maturity or after
notice of redemption or prepayment or otherwise).

     “Bond Purchase Drawing” means a Bond Purchase Interest Drawing or a Bond Purchase Principal
Drawing.

     “Bond Purchase Interest Drawing” and “Bond Purchase Principal Drawing” each has the meaning
given to that term by the Letters of Credit.

     “Bonds” means, collectively, the Series A Bonds and the Series B Bonds.

     “Bonds Tendered or Deemed Tendered for Purchase” has the meaning given to that term in the
Letters of Credit.

     “Business Day” or “business day” means a day on which (a) banks located in any of the cities
in which the Principal Office of the Trustee, the Bank, the Paying Agent and the Remarketing Agent
is located are not required or authorized by law or executive order to close for business, and (b)
The New York Stock Exchange is not closed.

     “Collateral Pledge Agreement” means the Collateral Pledge Agreement of even date herewith by
and among the Lessee, as Pledgor, the Bank, as Pledgee, and Manufacturers and Traders Trust
Company, acting in its capacity as Collateral Agent, together with any and all Supplements thereto.

     “Condemnation Award” has the meaning given to that term in the granting clauses of the Deed of
Trust.

     “Deed of Trust” means the Amended and Restated Deed of Trust of even date herewith between the
Issuer and the Individual Trustees, together with any and all Supplements thereto.

     “Downgrade” shall mean a withdrawal or a downgrading of one full grade from the long term debt
ratings of the Bank as of the date hereof.

     “Eligible Lease Payments” means all payments made by the Lessee under the Facility Lease
except (a) any common area maintenance fee or rent or similar charge under the Facility Lease and
(b) $1,250 per month.

3

 

     “Event of Default” and “Events of Default” shall have the meanings given to such terms in
Section 8.1 hereof.

     “Facility” means the Additional Improvements located on the Land.

     “Facility Lease” means the Amended and Restated Lease Agreement of even date herewith between
the Issuer and the Lessee, pursuant to which the Issuer leases the Additional Improvements to the
Lessee, together with any and all Supplements thereto.

     “Fixed Rate”, “Fixed Rate Date” and “Fixed Rate Period” each has the meaning given to that
term by the Indenture.

     “Government Acts” shall have the meaning given to such term in Section 7.2 hereof.

     “Improvements” has the meaning given to that term in the granting clauses of the Deed of
Trust.

     “Indenture” means the Amended and Restated Trust Indenture of even date herewith between the
Issuer and the Trustee, together with any and all Supplements thereto.

     “Individual Trustees” means the individual trustees acting as trustees under the Deed of
Trust, or their successors in trust who may be acting under and pursuant to the Deed of Trust from
time to time.

     “Interest Drawing” has the meaning given to that term by the Letters of Credit.

     “Interest Payment Date” has the meaning given to that term by the Indenture.

     “Issuer” means Maryland Economic Development Corporation, a body politic and corporate and a
public instrumentality of the State, its successors and assigns.

     “Issuer’s Bond Obligations” means the limited obligations of the Issuer under the Bond
Documents to (a) pay solely from the Trust Estate the principal of, premium (if any) and interest
on, and purchase price of, the Bonds as required by Section 7.2 of the Indenture, when and as the
same become due and payable (whether at the stated maturity thereof, or by acceleration of maturity
or after notice of redemption or prepayment or otherwise), (b) pay from the sources described in
Section 4.4 of the Indenture the purchase price of Bonds Tendered or Deemed Tendered for Purchase,
(c) pay solely from Eligible Lease Payments all other payments required by the Bond Documents to be
paid by the Issuer to the Trustee or to others, when and as the same shall become due and payable,
and (d) timely perform, observe and comply with all of the terms, covenants, conditions,
stipulations, and agreements, express or implied, which the Issuer is required by the Bond
Documents to perform or observe.

     “Issuer’s Letter of Credit Obligations” means the limited obligations of the Issuer under the
Letter of Credit Documents to pay all payments required by the Letter of Credit Documents, when and
as the same become due and payable, and timely perform, observe and comply with all terms,
covenants, conditions, stipulations and agreements, express or implied, which the Issuer is

4

 

required by the Letter of Credit Documents to observe or perform. The “Issuer’s Letter of
Credit Obligations” constitute “Issuer’s Credit Facility Obligations” (as defined in the
Indenture).

     “Land” means the 10-acre (approximate) tract of land located in Montgomery County, Maryland,
and more particularly described in Exhibit A attached to the Deed of Trust and made a part thereof,
together with any and all improvements thereon.

     “Lessee” means Human Genome Sciences, Inc., a Delaware corporation, its successors and
assigns.

     “Letters of Credit” means, collectively, the Series A Bonds Letter of Credit and the Series B
Bonds Letter of Credit.

     “Letter of Credit Agreements” means, collectively, the Series A Bonds Letter of Credit
Agreement and the Series B Bonds Letter of Credit Agreement.

     “Letter of Credit Documents” means the Letters of Credit, the Letter of Credit Agreements, the
Deed of Trust, the Pledge and Security Agreement, the Pledged Bonds Custody Agreement, the Facility
Lease, the Assignment of Leases, the Swap Agreement, the Standstill Agreement, and any and all
other documents which the Issuer or any other party or parties or their representatives, have
executed and delivered, or may hereafter execute and deliver, to evidence or secure the Issuer’s
Letter of Credit Obligations, or any part thereof, or in connection therewith, together with any
and all Supplements thereto. The “Letter of Credit Documents” constitute “Credit Facility
Documents” (as defined in the Indenture).

     “LIBOR Rate” means the fluctuating annual rate of interest which shall at all times equal the
interest rate which the Bank announces and declares from time to time to be its one (1) month
London Interbank Offered Rate, adjusted for any Federal Reserve Board requirements imposed on the
Bank from time to time. All interest at the LIBOR Rate or computed thereon shall be calculated on
the basis of a 360 day-year factor applied to actual days elapsed and shall be adjusted on any date
on which a change occurs in the LIBOR Rate.

     “Mandatory Tender Date” and “Mandatory Tender Notice” each has the meaning given to that term
by the Indenture.

     “Outstanding”, “outstanding” or “Bonds Outstanding” has the meaning given to that term by the
Indenture.

     “Owner” or “Owners” or “Owner of Bonds” or “Owners of Bonds” means the person or persons in
whose name any Bond is registered on the books of the Issuer maintained by the Registrar.

     “Paying Agent” means the Trustee, or any successor Paying Agent appointed under the Indenture.

     “Penalty Rate” means the fluctuating rate per annum which is at all times equal to the
Reimbursement Rate plus 2% per annum.

5

 

     “Permitted Encumbrances” has the meaning given to that term by the Deed of Trust.

     “Person” or “person” means any natural person, firm, association, corporation, company, trust,
partnership, public body or other entity.

     “Placement and Remarketing Agreement” means (a) the Amended and Restated Placement and
Remarketing Agreement of even date herewith by and between the Remarketing Agent and the Issuer,
together with any and all Supplements thereto, and (b) any other Remarketing Agreement or similar
agreement by and between the Remarketing Agent and the Issuer, pursuant to which the Remarketing
Agent agrees to use its best efforts to remarket and sell Bonds Tendered or Deemed Tendered for
Purchase, together with any and all Supplements thereto.

     “Pledge and Security Agreement” means, collectively, (a) the Series A Bonds Pledge and
Security Agreement, (b) the Series B Bonds Pledge and Security Agreement and (c) any other pledge
and security agreement or similar agreement between the Issuer and the Credit Facility Provider
pursuant to which Pledged Bonds are pledged as security for the Issuer’s Credit Facility
Obligations, together with any and all Supplements thereto.

     “Pledged Bonds” means Bonds that, subsequent to a Bond Purchase Principal Drawing, are
delivered to and held by the Pledged Bonds Custodian as security for the Issuer’s Letter of Credit
Obligations and registered as directed by the Bank.

     “Pledged Bonds Custodian” means Manufacturers and Traders Trust Company, as agent for the Bank
under the Pledged Bonds Custody Agreement, or any successor custodian of the Pledged Bonds acting
as the Bank’s agent.

     “Pledged Bonds Custody Agreement” means, collectively, (a) the Series A Bonds Pledged Bonds
Custody Agreement and (b) the Series B Bonds Pledged Bonds Custody Agreement, together with any and
all Supplements thereto.

     “Principal Drawing” has the meaning given to that term by the Letters of Credit.

     “Principal Office” means, with respect to the Trustee, the Registrar, the Paying Agent, the
Remarketing Agent, or the Bank, the office designated as such, from time to time, by the respective
party in writing to the Issuer, the Trustee, the Paying Agent, the Registrar, the Remarketing
Agent, and the Bank.

     “Property” means the Land, the Improvements, and all other items of property included in the
term “Property” as used and defined in the granting clauses of the Deed of Trust.

     “Registrar” or “Bond Registrar” means the Trustee, or any successor Registrar appointed under
the Indenture.

     “Reimbursement Rate” means the fluctuating rate of interest which is at all times equal to the
LIBOR Rate plus 1% per annum.

6

 

     “Remarketing Agent” means Manufacturers and Traders Trust Company, or any successor
Remarketing Agent appointed under the Indenture.

     “Series A Bonds” means the Issuer’s $4,375,000 Taxable Variable Rate Demand/Fixed Rate Revenue
Bonds (Human Genome Sciences, Inc. Facility), Series 1999 A, issued pursuant to the Indenture.

     “Series A Bonds Letter of Credit” means the Irrevocable Transferable Direct-Pay Letter of
Credit No. SB-902681-0101 issued by the Bank’s predecessor in interest, Allfirst, to secure the
Series A Bonds and dated December 30, 1999. Any extension, amendment or renewal of or substitution
issued by the Bank for Letter of Credit No. SB-902681-0101 shall, without any action on the part of
the Issuer, the Trustee or the Bank, be deemed an amendment to Exhibit A to the Series A Bonds
Letter of Credit Agreement and shall be deemed a part of Letter of Credit No. SB-902681-0101 as
herein described.

     “Series A Bonds Letter of Credit Agreement” means the Amended and Restated Letter of Credit
Agreement of even date herewith between the Issuer and the Bank, together with any and all
Supplements thereto.

     “Series A Bonds Pledge and Security Agreement” means the Amended and Restated Pledge and
Security Agreement of even date herewith between the Issuer and the Bank, together with any and all
Supplements thereto.

     “Series A Bonds Pledged Bonds Custody Agreement” means the Amended and Restated Pledged Bonds
Custody Agreement of even date herewith between the Bank and the Pledged Bonds Custodian, together
with any and all Supplements thereto.

     “Series B Bonds” means the Issuer’s $13,125,000 Taxable Variable Rate Demand/Fixed Rate
Revenue Bonds (Human Genome Sciences, Inc. Facility), Series 1999 B, issued pursuant to the
Indenture.

     “Series B Bonds Letter of Credit” means the Irrevocable Transferable Direct-Pay Letter of
Credit No. SB-913158-0001 issued by the Bank to secure the Series B Bonds and dated the date
hereof. Any extension, amendment or renewal of or substitution issued by the Bank for Letter of
Credit No. SB-913185-0001 shall, without any action on the part of the Issuer, the Trustee or the
Bank, be deemed an amendment to Exhibit A to the Series B Bonds Letter of Credit Agreement and
shall be deemed to be part of Letter of Credit No. SB-913185-0001 as herein described.

     “Series B Bonds Letter of Credit Agreement” means the Letter of Credit Agreement of even date
herewith between the Issuer and the Bank, together with any and all Supplements thereto.

     “Series B Bonds Pledge and Security Agreement” means the Pledge and Security Agreement of even
date herewith between the Issuer and the Bank, together with any and all Supplements thereto.

7

 

     “Series B Bonds Pledged Bonds Custody Agreement” means the Pledged Bonds Custody Agreement of
even date herewith between the Bank and the Pledged Bonds Custodian, together with any and all
Supplements thereto.

     “Sinking Fund Installment” and “Sinking Fund Installment Date” each has the meaning given to
that term by the Indenture.

     “Standstill Agreement” means the Amended and Restated Standstill and Subordination Agreement
of even date herewith among the Bank and the Maryland Department of Business and Economic
Development, together with any and all Supplements thereto.

     “State” means the State of Maryland.

     “Supplement” or “Supplements” means any and all extensions, renewals, modifications,
amendments, supplements and substitutions.

     “Swap Agreement” means, collectively, any ISDA Master Agreement and attached Schedules
executed and delivered at any time and from time to time whether before or on or after the date
hereof by the Issuer and the Bank, and any and all other documents relating to such Master
Agreement, and any and all replacements of or substitutions for such Master Agreement or such other
documents, as any such Master Agreement and other documents with attached Schedules or any such
replacement or substitution thereof may at any time or from time to time be amended, restated,
supplemented or otherwise modified.

     “Swap Obligations” means and includes all present and future indebtedness, obligations and
liabilities of the Issuer to the Bank of any nature whatsoever under or in connection with the Swap
Agreement, whether such indebtedness, obligations and liabilities are direct or indirect, secured
or unsecured, joint or several, absolute or contingent, due or to become due, or now existing or
hereafter arising. The Swap Obligations constitute part of the Issuer’s Letter of Credit
Obligations.

     “Taxes” means all taxes, water rents, sewer rents, assessments and other governmental or
municipal or public or private dues, charges and levies and any prior liens (including federal tax
liens) for the Taxes which are or may be levied, imposed or assessed upon the Property or any part
thereof, or any leases pertaining thereto, or upon the rents, issues, income or profits thereof,
whether any or all of the aforementioned be levied directly or indirectly or as excise taxes or as
income taxes.

     “Trust Estate” has the meaning given to that term by the Indenture.

     “Trustee” means Manufacturers and Traders Trust Company, a New York banking corporation having
its Principal Office in Baltimore, Maryland, and its successor or successors in the trust created
by the Indenture.

     “Variable Rate” has the meaning given to that term by the Indenture.

     “1997 Bond Documents” means the Bond Documents as defined in the 1997 Indenture, together with
any and all Supplements thereto.

8

 

     “1997 Bonds” means the $23,000,000 Maryland Economic Development Corporation Taxable Variable
Rate Demand/Fixed Rate Revenue Bonds (Human Genome Sciences, Inc. Facility) 1997 Issue.

     “1997 Indenture” means the Trust Indenture dated as of December 1, 1997 between the Issuer and
FMB Trust Company, National Association, predecessor in interest to the Trustee, executed in
connection with the 1997 Bonds, together with any and all Supplements thereto.

     “1997 Letter of Credit Documents” means the Letter of Credit Documents as defined in the 1997
Indenture, together with any and all Supplements thereto.

ACCOUNTING TERMS

     Unless specifically provided otherwise, all accounting terms have the definitions given them
in accordance with generally accepted accounting principles as applied to the applicable person on
a consistent basis by its accountants in the preparation of its previous annual financial
statements.

     Section 1.2 Rules of Construction. The words “hereof”, “herein”, “hereunder”,
“hereto”, and other words of similar import refer to this Reimbursement Agreement in its entirety.

     The terms “agree” and “agreements” contained herein are intended to include and mean
“covenant” and “covenants”.

     References to Articles, Sections, and other subdivisions of this Reimbursement Agreement are
to the designated Articles, Sections, and other subdivisions of this Reimbursement Agreement as
originally executed.

     The headings of this Reimbursement Agreement are for convenience only and shall not define or
limit the provisions hereof.

     All references made (a) in the neuter, masculine or feminine gender shall be deemed to have
been made in all such genders, and (b) in the singular or plural number shall be deemed to have
been made, respectively, in the plural or singular number as well.

ARTICLE II

EFFECTIVE DATE OF REIMBURSEMENT AGREEMENT;

DURATION OF TERM

     Section 2.1 Effective Date of Reimbursement Agreement; Duration of Term. This
Reimbursement Agreement shall become effective on the date hereof and shall continue in full force
and effect until (a) the Letters of Credit have expired as therein provided, and (b) all of
the Lessee’s obligations under this Reimbursement Agreement have been fully performed and
satisfied.

9

 

     In the event that an Act of Bankruptcy has occurred on or prior to the satisfaction of the
conditions specified in the immediately preceding paragraph,, then this Reimbursement Agreement
shall continue in full force and effect, and shall not expire, until (a) the Letters of Credit have
expired in accordance with their terms, (b) all of the Lessee’s obligations hereunder have been
fully performed and satisfied, and (c) either (i) a final order has been issued, holding
that the Bank is not required to return any funds it has received from the Issuer or the Lessee, or
(ii) all statutes of limitation for all causes of action under Chapter 5 of the Bankruptcy Code
have expired.

ARTICLE III

PAYMENT PROVISIONS

     Section 3.1 Reimbursement and Other Payments. In consideration for the Bank’s
agreement to extend the Series A Bonds Letter of Credit and to issue the Series B Bonds Letter of
Credit, the Lessee hereby unconditionally acknowledges and agrees, for the benefit of the Bank, to
pay and perform all of the Issuer’s Letter of Credit Obligations, including, without limitation,
the Issuer’s obligation to reimburse the Bank for all amounts drawn under the Letters of Credit and
all other amounts advanced or paid by the Bank, plus all expenses, indemnities and other amounts
payable to or for the benefit of the Bank under the Letter of Credit Agreements, as and when the
same shall become due and payable, provided however, that all such obligations shall be payable by
the Lessee on a full recourse basis without regard to Section 14.15 of the Letter of Credit
Agreements, and all of the obligations of the Lessee under this Reimbursement Agreement, and such
obligations of the Lessee shall include, without limitation, the Lessee’s unconditional promise to
pay to the Bank:

          (a) immediately on demand by the Bank, a sum equal to (i) any amount drawn under, or paid by
the Bank in good faith under, the Letters of Credit pursuant to a Bond Purchase Principal Drawing,
plus (ii) interest on such amount as provided in paragraph (j) below;

          (b) immediately and no later than 5:00 p.m. (without the necessity of any demand by or notice
from the Bank) on each date that the Bank pays any amount drawn under, or paid by the Bank in good
faith under, the Letters of Credit pursuant to a Principal Drawing or an Interest Drawing or an
Acceleration Drawing, a sum equal to (i) such amount so drawn under, or paid by the Bank in good
faith under, the Letters of Credit pursuant to a Principal Drawing or an Interest Drawing or an
Acceleration Drawing, plus (ii) interest on such amount as provided in paragraph (j) below;

          (c) immediately on demand by the Bank, any amount drawn under, or paid by the Bank in good
faith under, the Letters of Credit pursuant to a Bond Purchase Interest Drawing, a sum equal to (i)
such amount so drawn under, or paid by the Bank in good faith under, the Letters of Credit pursuant
to a Bond Purchase Interest Drawing, plus (ii) interest on such amount as provided in paragraph (j)
below

          (d) immediately on demand by the Bank, a sum equal to (i) any and all reasonable charges and
expenses (excluding the Bank’s internal overhead) which the Bank may pay or incur relative to the
payment of any draft drawn under, or paid by the Bank in good faith

10

 

under, the Letters of Credit or in connection with any amendment or extension of or
substitution for or renewal of the Letters of Credit, plus (ii) interest thereon as provided in
paragraph (j) below;

          (e) immediately on demand by the Bank, a sum equal to (i) the amount advanced or paid by the
Bank pursuant to the provisions of Section 4.7 or Section 14.9 of the Letter of
Credit Agreements, plus (ii) interest on such amount as provided in paragraph (j) below, plus (iii)
any and all reasonable charges and expenses which the Bank may pay or incur relative to such
payment;

          (f) immediately (without the necessity of any demand by or notice from the Bank) as and when
due and payable, the Letter of Credit Fee and the Negotiation Fee as set forth in Section
4.1 of the Letter of Credit Agreements (including any additional amounts required by
Section 5.4 of the Letter of Credit Agreements), plus interest thereon as provided in
paragraph (j) below;

          (g) immediately on demand by the Bank, any and all expenses incurred by the Bank in enforcing
any rights under the Letter of Credit Agreements or this Reimbursement Agreement plus interest
thereon as provided in paragraph (j) below;

          (h) immediately on demand by the Bank, all other costs and expenses of the Bank, as set forth
in the Letter of Credit Agreements (including, without limitation, all costs and expenses payable
pursuant to Section 4.6 of the Letter of Credit Agreements) plus interest thereon as
provided in paragraph (j) below;

          (i) immediately on demand by the Bank upon any transfer of the Letters of Credit, the transfer
charge payable to the Bank pursuant to the Letters of Credit ($750) plus interest thereon as
provided in paragraph (j) below (a “transfer” of the Letters of Credit means the designation of a
new beneficiary thereunder as a substitute Trustee under the Indenture); and

          (j) immediately on demand by the Bank, interest on any and all amounts and sums payable by the
Lessee under this Reimbursement Agreement at any time (including, without limitation, any and all
amounts or sums described or referred to in paragraphs (a) through (i) above), such interest being
payable from the date such amounts and sums become due until the Bank actually receives payment
thereof in full, at the Reimbursement Rate. Interest on any amounts advanced or paid by the Bank
or any costs, charges and expenses incurred by the Bank shall be due and payable from the date such
amounts are advanced or costs are incurred or paid by the Bank until the Bank actually receives
payment thereof in full at the Reimbursement Rate; provided, however, notwithstanding the foregoing
provisions of this paragraph, interest on the amounts due pursuant to paragraphs (d), (f) and (h)
shall not be due and payable until 15 days after notice to the Lessee of the amounts due.

     The Bank and the Lessee contemplate that pursuant to the Indenture, the amounts paid by the
Bank under the Letters of Credit pursuant to a Principal Drawing or an Interest Drawing or a Bond
Purchase Interest Drawing, will, in the ordinary course, be repaid directly to the Bank by the
Trustee from certain payments made to the Issuer by the Lessee pursuant to the Facility Lease,
which payments are to be deposited by the Trustee in the Bond Fund. The Lessee shall

11

 

not, however, be relieved of liability for repaying any such amounts (plus interest thereon,
at the Reimbursement Rate, from the date such amounts are paid by the Bank under the Letters of
Credit) to the Bank by reason of any action or inaction on the part of the Trustee or any other
person which results in a failure by the Bank to actually receive such amounts from the Trustee
pursuant to the Indenture or results in any delay in the receipt by the Bank of such amount from
the Trustee pursuant to the Indenture.

     All amounts paid by the Bank under the Letters of Credit shall bear interest from the date
such amounts are paid by the Bank until such time as such amounts are actually repaid to the Bank.

     In connection with the foregoing, the Lessee acknowledges and agrees as follows: (a) the
Issuer shall apply any and all amounts which it receives in respect of the principal of and
interest on the Pledged Bonds to the repayment of amounts from time to time owing to the Bank under
the Letter of Credit Agreements; and (b) notwithstanding any other terms and provisions of any of
the Letter of Credit Documents, the amounts set forth hereinabove shall be due and payable in full
by the Lessee at the time indicated, regardless of whether or not the Bank (or the Pledged Bonds
Custodian, for the account of the Bank) is then holding any Pledged Bonds as a result of any Bond
Purchase Principal Drawing and regardless of whether or not the Bank (in its sole discretion) has
theretofore extended the time for payment of any amounts payable by the Lessee hereunder.

     Notwithstanding anything to the contrary set forth in this Section, following the date on
which the Bank honors a Bond Purchase Principal Drawing, the Bank will not make demand for the
payment of the amounts payable under paragraph (a) above in connection with such Bond Purchase
Principal Drawing, so long as (1) within 48 hours after the Bank honors such Bond Purchase
Principal Drawing (or such longer period of time not to exceed five Business Days if the Trustee
advises the Bank that the delay is caused by administrative difficulties), the Pledged Bonds
Custodian receives an aggregate principal amount of Bonds equal to the amount of such Bond Purchase
Principal Drawing, registered by the Trustee in the Issuer’s name, as owner, and in the Bank’s
name, as pledgee, (2) the Bank actually receives all payments of the principal of and interest on
such Bonds, when due, (3) no Event of Default shall have occurred and be continuing, and (4) the
Letters of Credit shall not have expired. On the date of the expiration of the Letters of Credit,
all amounts payable under paragraph (a) above in connection with such Bond Purchase Principal
Drawing which shall not have been repaid, together with all accrued and unpaid interest thereon,
shall become immediately due and payable, without the necessity of any demand by or notice from the
Bank; provided, however, if such Bond Purchase Principal Drawing is the result of a Downgrade, all
amounts payable in connection with such Bond Purchase Principal Drawing which shall not have been
repaid, together with all accrued and unpaid interest thereon, shall become immediately due and
payable, without demand or notice from the Bank, on the day which is 180 days following the date on
which the Bank honors such Bond Purchase Principal Drawing.

     Section 3.2 Payments due Upon Expiration of Letters of Credit. On the date on which
the Letters of Credit expire, all amounts described in Section 3.1 above, and all other amounts
owed to the Bank hereunder, together with all accrued and unpaid interest thereon, shall become
immediately due and payable, without the necessity of any demand or notice from the Bank.

12

 

     Section 3.3 Late Payments. In the event any payment required to be made by the Lessee
in accordance with the provisions of Section 3.1 or Section 3.2 hereof or in accordance with any
other provision of this Reimbursement Agreement is not paid within 15 days from the date on which
the same is due and payable, such payment in default shall continue as an obligation of the Lessee,
and such payment in default and the entire unpaid balance of all amounts owing hereunder shall bear
interest, from the date on which the payment was due until such payment in default is paid in full,
at the fluctuating rate which is at all times equal to the Penalty Rate. In addition, the Lessee
shall pay (a) a late charge in an amount equal to 2% of the amount of any payment which is made
more than 15 days after the date on which the same is due and payable (except for any payment with
respect to a Bond Purchase Principal Drawing), and (b) all costs of collection, including
reasonable attorneys’ fees, if this Reimbursement Agreement is referred to an attorney for
collection after default by the Issuer.

     Section 3.4 Increased Costs Due to Change in Law. If any change in any law,
regulation or official directive of any international, federal, state or local governmental
authority (whether or not having the force of law) or in the interpretation thereof by any court or
administrative agency or compliance by the Bank with any lawful request, law, regulation or
directive from any applicable fiscal or monetary authority (whether or not having the force of law)
shall either:

          (a) impose, modify or render applicable any reserve, special deposit or similar requirement
against letters of credit issued by the Bank or require the inclusion of such letters of credit in
any analysis of minimum capital requirements or capital adequacy; or

          (b) subject the Bank to any tax with respect to such letters of credit or any amount payable
under the Letter of Credit Agreements (other than a tax on the overall net income of the Bank)
imposed by the United States of America or the State; or

          (c) impose on the Bank any other condition regarding the Letter of Credit Agreements or the
Letters of Credit, and the result of any such event shall be:

          (i) to increase the cost to the Bank of issuing or maintaining the Letters of Credit or
any renewal thereof or of making, funding or maintaining the whole or any part of any unpaid
drawing under the Letters of Credit (which increase in cost shall be determined by the
Bank’s reasonable allocation of the aggregate of such cost increases resulting from such
events); or

          (ii) to reduce the amount of any sum received or receivable by the Bank under the
Letter of Credit Agreements or to require the Bank to make any payment or forego any
interest; or

          (iii) to reduce the rate of return on the Bank’s capital as a result of issuing or
maintaining the Letters of Credit and/or any renewals thereof (which reduction shall be
determined by the Bank taking into consideration the Bank’s policies concerning capital
adequacy),

then and in each such case, within five (5) days following the Lessee’s receipt of demand therefor
from the Bank, the Lessee shall pay to the Bank, from time to time as specified by the

13

 

Bank, additional amounts which shall be sufficient to compensate the Bank for such increased cost,
reduction, payment or foregone interest, together with interest on each such amount from the date
demanded until payment in full thereof at the Reimbursement Rate. A certificate as to each such
increased cost, reduction, payment or foregone interest as a result of any such event, submitted in
good faith by the Bank to the Lessee, shall be conclusive evidence of such additional amounts to be
paid by the Lessee and the basis therefor, absent manifest error as to the amount thereof.

     Section 3.5 Computation. All payments of interest and other charges under this
Reimbursement Agreement shall be computed on the basis of a 360-day year factor applied to the
actual number of days elapsed. The rate of interest shall be adjusted on any day on which a change
occurs in the LIBOR Rate.

     Section 3.6 Payment Procedure. All payments made by the Lessee under this
Reimbursement Agreement shall be made to the Bank in lawful money of the United States of America
at the time of payment and in immediately available funds at the Bank’s offices at 25 South Charles
Street, Baltimore, Maryland 21201, before 12:00 noon, prevailing Baltimore, Maryland time on the
date when due.

     Section 3.7 Business Days. If the date for any payment hereunder is a day which is
not a Business Day, then for all purposes of this Reimbursement Agreement the payment then due
shall be made on the next following Business Day, and such extension of time shall in each case be
included in any computation of payments of interest.

ARTICLE IV

UNCONDITIONAL OBLIGATIONS

     Section 4.1 Obligations Absolute. The obligations of the Lessee under this
Reimbursement Agreement shall be paid strictly in accordance with the terms of this Reimbursement
Agreement, under any and all circumstances whatsoever; including, without limitation, the following
circumstances: (a) any invalidity or unenforceability of the Letters of Credit, the Letter of
Credit Agreements or any other agreement or instrument related thereto; (b) any amendment or waiver
of, or any consent to or departure from, the terms of the Letters of Credit, the Letter of Credit
Agreements or any other agreement or instrument related thereto; (c) the existence of any claim,
set-off, defense or other right which the Lessee may have at any time against any beneficiary or
any transferee of the Letters of Credit (or any person for whom the Lessee, any such beneficiary or
any such transferee may be acting), the Bank or any other Person, whether in connection with this
Reimbursement Agreement or any unrelated transaction; (d) any statement or any other document
presented under the Letters of Credit proving to be forged, fraudulent, invalid or insufficient in
any respect, or any statement therein being untrue or inaccurate in any respect whatsoever; (e)
payment by the Bank under the Letters of Credit against presentation of a sight draft or
certificate which substantially complies with the terms of the Letters of Credit; (f) the surrender
or impairment of any security for the performance or observance of any of the agreements or terms
of the Letter of Credit Agreements or this Reimbursement Agreement; or (g) any other circumstance,
happening or omission whatsoever, whether or not similar to any of the foregoing. The Lessee
understands and agrees that no

14

 

payment under any other agreement will release it from liability hereunder unless the Bank has
been indefeasibly paid in full.

ARTICLE V

REPRESENTATIONS AND WARRANTIES

     Section 5.1 Representations, Warranties and Undertakings. The Lessee makes the
following representations and warranties to induce the Bank to enter into this Reimbursement
Agreement, to enter into the Letter of Credit Agreements, to extend the Series A Bonds Letter of
Credit and to issue the Series B Bonds Letter of Credit:

          (a) Authority. The Lessee is a corporation duly organized and validly existing under
the laws of the State of Delaware. The Lessee has the power to enter into this Reimbursement
Agreement and the transactions contemplated hereunder and to carry out its obligations hereunder.
By proper action, the Lessee has duly authorized the execution and delivery of this Reimbursement
Agreement.

          (b) Binding Agreements. This Reimbursement Agreement and the Letter of Credit
Documents to which the Lessee is a party have been duly and properly authorized, executed, sealed
and delivered by the Lessee, constitutes valid and legally binding obligations of the Lessee, and
is fully enforceable against the Lessee in accordance with their respective terms; provided,
however, that the enforceability and binding nature of this Reimbursement Agreement and the Letter
of Credit Documents to which the Lessee is a party are subject to bankruptcy, insolvency,
reorganization and other state and federal laws affecting the enforcement of creditors’ rights
generally, and, to the extent that certain remedies under such instruments require, or may require,
enforcement by a court of equity, such principles of equity as the court having jurisdiction may
impose.

          (c) Litigation. There are no proceedings pending or, to the knowledge of the Lessee,
threatened in writing before any court or administrative agency which may affect the authority of
the Lessee to enter into this Reimbursement Agreement or the Letter of Credit Documents to which
the Lessee is a party.

          (d) No Conflicting Agreements, Laws, etc. The execution, delivery and performance by
the Lessee of this Reimbursement Agreement and the Letter of Credit Documents to which the Lessee
is a party, or any other document required to be delivered hereby by the Lessee, do not constitute
a violation or breach of or a default under the Bylaws of the Lessee or any existing mortgage,
indenture, contract, instrument or agreement binding on the Lessee or affecting its property, or
any provision of law or order of any court binding upon the Lessee.

          (e) Liens or Security Interests. Except for liens being granted to the Bank, there
exist no liens or security interests on or with respect to the Property (other than Permitted
Encumbrances) or with respect to any security provided by the Lessee to the Bank for the Lessee’s
obligations under this Reimbursement Agreement.

15

 

               (f) Full Disclosure. All information heretofore furnished by the Lessee to the Bank
in writing for purposes of or in connection with this Reimbursement Agreement or any transaction
contemplated hereby is, and all such information hereafter furnished by the Lessee to the Bank will
be, true and accurate in all material respects on the date as of which such information is stated
or certified.

ARTICLE VI

AFFIRMATIVE COVENANTS OF LESSEE

     Section 6.1 Affirmative Covenants of Lessee. Until the termination of this
Reimbursement Agreement, unless the prior written consent to do otherwise is obtained from the
Bank, the Lessee will:

               (a) Financial Statements. Furnish or cause to be furnished to the Bank the following:

     (i) as soon as available but in no event more than forty-five (45) days after filing
with the Securities and Exchange Commission (the “SEC”), a copy of the 10Q Report of the
Lessee filed with the SEC accompanied by a certificate of the chief financial officer of the
Lessee stating whether any event has occurred which constitutes an Event of Default, or
which would constitute such an Event of Default with the giving of notice or the lapse of
time or both, and, if so, stating the facts with respect thereto; and

     (ii) as soon as available but in no event more than one hundred twenty (120) days after
the close of each fiscal year of the Lessee, a copy of the 10K Report of the Lessee filed
with the SEC and a copy of the annual audited financial statements relating to the Lessee
prepared in accordance with GAAP, which financial statements shall include a balance sheet
of the Lessee as at the end of such fiscal year and a statement of earnings and changes in
stockholder’s equity of the Lessee for such fiscal year; and

     (iii) promptly upon transmission thereof, copies of any financial statements, proxy
statements, reports and the like which the Lessee sends to its shareholders and copies of
all registration statements (with exhibits); and

     (iv) with reasonable promptness, such budgets, cash flow projections, financial
forecasts and other additional information, reports or statements as the Bank may from time
to time reasonably request concerning the Lessee, the Property or any other matter related
to the transactions that are the subject of this Reimbursement Agreement.

               (b) Taxes and Claims. Pay and discharge or cause to be paid and discharged all Taxes
imposed upon the Property or any income derived therefrom prior to the date on which penalties
attach thereto, and all lawful claims which, if unpaid, might become a lien or charge upon the
property. The Lessee shall have the right to contest the validity of any such tax, assessment,
charge, levy or claim, by timely and appropriate proceedings, provided that the Lessee shall (a)
give the Bank written notice of its intention to contest, (b) diligently prosecute such contest,
(c) at all times effectively stay or prevent any official or judicial sale of the Property or any
part thereof by reason of nonpayment of any such taxes, and (d) establish

16

 

reasonable reserves for such liabilities being contested if the Bank reasonably determines
such reserves to be necessary.

          (c) Compliance with Laws. Comply with all applicable federal, State and local laws,
rules and regulations, subject to the Lessee’s right to contest the validity or applicability of
any of the foregoing, at its sole cost and expense, in good faith and by appropriate and diligent
proceedings.

          (d) Books and Records. Maintain appropriate books and records with respect to the
Property and permit access by the Bank and its authorized representatives and employees to the
books and records of the Lessee at the offices of the Lessee during normal business hours.

ARTICLE VII

INDEMNIFICATION

     Section 7.1 Indemnification of Bank. To the extent permitted by law, in addition to
all amounts payable hereunder, the Lessee shall protect, indemnify, and save harmless the Bank and
its officers, employees and agents against and from any and all liabilities, suits, actions,
claims, demands, losses, expenses and costs of every kind and nature incurred by, or asserted or
imposed against, the Bank and its officers, employees or agents, by reason of (a) any accident,
injury (including death) or damage to any person or property, however caused (other than the gross
negligence or willful misconduct of the Bank), resulting from, connected with or growing out of any
act of commission or omission of the Lessee, or any officers, employees, agents, assignees,
contractors or subcontractors of the Lessee or any use, non-use, possession, occupation, condition,
operation, service, design, construction, acquisition, maintenance or management of, or on, or in
connection with, the Property, or any part thereof; (b) federal and state securities laws,
including, without limitation, any failure to register the Bonds, the Letters of Credit or any
other “separate security” under federal or state securities laws; (c) solely with respect to
information about the Lessee provided by the Lessee, any untrue statement of a material fact or any
omission to state a material fact necessary in order to make any statements made, in light of the
circumstances under which they were made, not misleading in connection with the sale of the Bonds
(other than as a result of the gross negligence or willful misconduct of the Bank); and, in any
such case, regardless of whether such liabilities, suits, actions, claims, demands, damages,
losses, expenses and costs be against, or be suffered or sustained by, the Bank or its officers,
agents or employees, or be against, or be suffered or sustained by, legal entities, officers,
agents, or other persons to whom the Bank or its officers, agents or employees, become liable
therefor. The Lessee may, and if so requested by the Bank shall, undertake to defend, at its sole
cost and expense, any and all suits, actions and proceedings brought against the Bank or its
officers, agents or employees in connection with any of the matters indemnified against in this
Section. The Bank agrees to give the Lessee timely notice of and shall forward to the Lessee every
demand, notice, summons or other process received with respect to any claim or legal proceedings
within the purview hereof, but the failure of the Bank to give such notice shall not affect its
right to indemnification hereunder, unless such failure shall have deprived the Lessee of a
reasonable opportunity to contest any such claim or legal proceeding.

17

 

     If the indemnification provided for herein is held by a court to be unavailable or is
insufficient to hold the Bank harmless in respect of any losses, claims, damages or liabilities (or
actions in respect thereof), then the Lessee shall contribute to the amount paid or payable by the
Bank as a result of the losses, claims, damages or liabilities (or actions in respect thereof)
(except those caused by the gross negligence or willful misconduct of the Bank) in such proportion
as is appropriate to reflect the relative fault of the Lessee on the one hand and the Bank on the
other hand, as well as any other relevant equitable considerations.

     Section 7.2 Indemnification Under Letters of Credit and Letter of Credit Agreements.
In addition to all amounts payable hereunder and to the extent permitted by law, the Lessee hereby
protects, indemnifies and holds harmless the Bank from and against, and hereby agrees to defend the
Bank against, any and all claims, damages, losses, liabilities, costs or expenses whatsoever which
the Bank may, at any time, sustain or incur by reason of or in consequence of or arising out of the
issuance of the Letters of Credit; it being the intention of the parties that this Reimbursement
Agreement shall be construed and applied to protect and indemnify the Bank against any and all
risks involved in the issuance of the Letters of Credit all of which risks are hereby assumed by
the Lessee, including, without limitation, any and all risks of the acts or omissions, whether
rightful or wrongful, of any present or future de jure or de facto government or governmental
authority (all such acts or omissions, herein called “Government Acts”). Notwithstanding anything
to the contrary herein contained, the Lessee shall have no obligation to indemnify the Bank from
and against any liability incurred by the Bank arising solely out of the gross negligence or
willful misconduct of the Bank. The Bank shall not, in any way, be liable for any failure by the
Bank or anyone else to pay any drawing under the Letters of Credit as a result of any Government
Acts or any other cause beyond the control of the Bank. Nothing in this Section 7.2 is intended to
limit the Issuer’s reimbursement obligations contained in Article V hereof.

     The provisions of this Article shall survive the expiration of the Letters of Credit and the
termination of the Bond Documents and the Letter of Credit Documents.

ARTICLE VIII

EVENTS OF DEFAULT AND REMEDIES

     Section 8.1 Events of Default Defined. The following shall be “Events of Default”
under this Reimbursement Agreement, and the term “Event of Default” shall mean, whenever it is used
in this Reimbursement Agreement, any one or more of the following events:

          (a) Any representation or warranty made herein or any statement or representation made in any
certificate, report or opinion (including legal opinions), financial statement or other instrument
furnished by the Lessee in connection with this Reimbursement Agreement, the Letters of Credit or
the Letter of Credit Agreements, proves to have been incorrect, false or misleading in any material
respect when made; or

          (b) The Lessee fails to pay, on the date on which the same is due and payable as herein
provided, (i) any payment required by Article III hereof, or (ii) any other payment

18

 

whatsoever required by this Reimbursement Agreement to be paid by the Lessee; and any such
failure is not cured within 5 days after notice from the Bank to the Lessee; or

          (c) The Lessee fails to duly and promptly perform, comply with or observe any other term,
covenant, condition or agreement contained in this Reimbursement Agreement, which failure remains
unremedied for 30 days after written notice thereof shall have been given to the Lessee by the
Bank; provided, however, if such failure be such that it cannot be corrected within 30 days, it
shall not be an Event of Default if, in the reasonable opinion of the Bank, the Lessee is taking
appropriate corrective action to cure the failure and if such failure will not impair the ability
of the Lessee to pay or perform the Lessee’s obligations under this Reimbursement Agreement; or

          (d) An Act of Bankruptcy occurs with respect to the Lessee or the Lessee becomes generally
unable to pay its debts as they become due; provided, however, if a proceeding with respect to an
Act of Bankruptcy is filed or commenced against the Lessee, the same shall not constitute an Event
of Default if such proceeding is dismissed within 60 days from the date of such Act of Bankruptcy;
or

          (e) An “event of default” or “Event of Default” occurs under the Collateral Pledge Agreement,
any of the Bond Documents, any of the Letter of Credit Documents, any of the 1997 Bond Documents or
any of the 1997 Letter of Credit Documents; or

          (f) Any execution or attachment is levied against the Lessee’s interest in the Property, or
any part thereof, and such execution or attachment is not set aside, discharged, bonded against, or
stayed within 30 days after the same is levied; or

          (g) Any change in any zoning ordinance or any other public restriction is enacted, limiting or
defining the uses which may be made of the Property or a part thereof, such that the existing use
of the Property, as specified in the Letter of Credit Documents, would not be permitted after such
restriction or zoning change; or

          (h) The Lessee fails to comply with any requirement of any governmental authority having
jurisdiction over the Property within the time required by such governmental authority; or any
proceeding is commenced or action taken to enforce any remedy for a violation of any requirement of
a governmental authority or any restrictive covenant affecting the Property or any part thereof;
provided, however, such failure shall not be an Event of Default if the Lessee is diligently
contesting such requirement in good faith; or

          (i) Any amendment to any of the Bond Documents or the Letter of Credit Documents shall have
been made without the prior written consent of the Bank; or

          (j) Notwithstanding the provisions of Section 9.5 hereof, if any material provision of this
Reimbursement Agreement at any time for any reason ceases to be valid and binding on the Lessee, or
is declared to be null and void, or the validity or enforceability thereof is contested by the
Lessee or any governmental agency or authority, or the Lessee denies that it has any or further
liability or obligation under this Reimbursement Agreement or any of the Bond Documents or the
Letter of Credit Documents; or

19

 

          (k) Within 48 hours following a Bond Purchase Principal Drawing (or such longer period of
time, not to exceed five Business Days, if the Trustee advises the Bank that the delay is caused by
administrative difficulties), the Trustee does not deliver, or cause to be delivered to the Pledged
Bonds Custodian an aggregate principal amount of Bonds equal to the amount of the Bond Purchase
Principal Drawing, registered in the name of the Bank, as pledgee; or

          (l) Any mechanics’ liens are established against the Property and are not caused to be
discharged or bonded against by the Lessee within 30 days after it receives notice of the
establishment thereof; or

          (m) The Facility Lease is terminated for any reason prior to the expiration or termination of
the Letters of Credit or the full payment and performance of all of the Lessee’s obligations under
this Reimbursement Agreement; provided, however, such termination shall not constitute an Event of
Default if it is as a result of the Lessee’s exercise of its option to purchase the Property
pursuant to the Facility Lease; or

          (n) The Deed of Trust, after delivery thereof, except to the extent permitted by the terms
thereof, ceases to create a valid and perfected lien or security interest, as appropriate, of the
priority required thereby, on any of the property purported to be covered thereby, or the Issuer or
any other person liable for the Issuer’s Letter of Credit Obligations so states in writing.

     Section 8.2 Remedies on Default. Whenever any Event of Default referred to in Section
8.1 hereof occurs, the Bank may take any one or more of the following remedial steps:

          (a) The Bank, at its option, may (i) demand that the Trustee exercise its remedies under the
Indenture and accelerate the maturity of the Bonds (in which event the Trustee is required to
immediately draw under the Letters of Credit pursuant to Section 9.2(a) of the Indenture), and (ii)
declare all amounts payable under Article III hereof (including amounts payable as a result of a
drawing under the Letters of Credit as described in clause (i) above), together with all other
moneys payable hereunder, to be immediately due and payable, whereupon the same shall become
immediately due and payable, by written notice to that effect given to the Lessee, without protest,
presentment, or further notice or demand, all of which are expressly waived by the Lessee. Upon
such declaration by the Bank, payment of all amounts due under Article III hereof (including
amounts payable as a result of a drawing under the Letters of Credit as described in clause (i)
above) shall be made immediately by the Lessee, and the Lessee hereby promises to pay such amount
immediately, to the Bank. Upon payment in full of all of the Lessee’s obligations under this
Reimbursement Agreement, whether contingent or otherwise, but only upon the expiration of this
Reimbursement Agreement, any remaining surplus of such funds held by the Bank as a result of
payment pursuant to this Section 8.2(a) shall be applied first to pay any unpaid Administration
Expenses and any remainder shall be returned to the Lessee, unless otherwise agreed by the Lessee
and the Bank.

          (b) The Bank may take whatever action at law or in equity may appear necessary or desirable to
collect the payments and other amounts then due and thereafter to become due or to enforce
performance and observance of all of the Lessee’s obligations under this Reimbursement Agreement.

20

 

          (c) The Bank, with or without resort to judicial process, may take such steps as the Bank
deems appropriate to protect the Property from depredation or injury, including (without
limitation) employment of watchmen or other protective services, and any expenses incurred by the
Bank in taking such steps shall be paid by the Lessee to the Bank as provided in Section 9.9
hereof.

          (d) The Bank may proceed under the Maryland Uniform Commercial Code (or under the Uniform
Commercial Code of any other jurisdiction in which any security for the Issuer’s Letter of Credit
Obligations may be located from time to time) as to all or any part of the security for the
Issuer’s Letter of Credit Obligations, and in conjunction therewith exercise all of the rights,
remedies and powers of a secured party under the Maryland Uniform Commercial Code (or under the
Uniform Commercial Code of any other jurisdiction in which any security for the Issuer’s Letter of
Credit Obligations may be located from time to time), including, without limitation, taking
possession of any security for the Lessee’s obligations under this Reimbursement Agreement without
judicial process pursuant to Section 9-609 of the Maryland Uniform Commercial Code. Upon the
occurrence of any Event of Default hereunder, the Lessee shall assemble all of the security for the
Lessee’s obligations under this Reimbursement Agreement, and make the same available to the Bank.
Any notification required by Section 9-611 of the Maryland Uniform Commercial Code shall be deemed
reasonably and properly given if mailed certified mail, return receipt requested, postage prepaid,
by the Bank to the Lessee at the address specified in Section 9.1 hereof at least 10 days before
any sale or other disposition of the security for the Lessee’s obligations under this Reimbursement
Agreement, or any portion thereof. Disposition of the security for the Lessee’s obligations under
this Reimbursement Agreement, or any portion thereof, shall be deemed commercially reasonable if
made pursuant to a public offering advertised at least twice in a newspaper of general circulation
in the community in which the Property is located.

          (e) The Bank may exercise any and all remedies available to it under the Collateral Pledge
Agreement, any of the Bond Documents and any of the Letter of Credit Documents.

     No action taken pursuant to this Section shall relieve the Lessee from any of the Lessee’s
obligations under this Reimbursement Agreement, all of which shall survive any such action, and the
Bank may take whatever action at law or in equity as may appear necessary and desirable to collect
the payments and other amounts then due and thereafter to become due or to enforce the performance
and observance of the Lessee’s obligations under this Reimbursement Agreement.

     Any amounts collected pursuant to action taken under this Section shall be paid over to the
Bank and applied to the Lessee’s obligations under this Reimbursement Agreement.

     Section 8.3 No Remedy Exclusive. No remedy herein conferred upon or reserved to the
Bank is intended to be exclusive of any other available remedy or remedies, but each and every such
remedy shall be cumulative and shall be in addition to every other remedy given under this
Reimbursement Agreement, the Collateral Pledge Agreement or any of the Letter of Credit Documents
or now or hereafter existing at law or in equity or by statute. No delay or omission to exercise
any right or power accruing upon any default shall impair any such right or power or shall be
construed to be a waiver thereof, but any such right and power may be

21

 

exercised from time to time and as often as may be deemed expedient. In order to entitle the
Bank to exercise any remedy reserved to it in this Article, it shall not be necessary to give any
notice, other than such notice as may be herein expressly required.

     Section 8.4 Agreement to Pay Attorneys’ Fees and Expenses. In the event the Lessee
defaults under any of the provisions of this Reimbursement Agreement, and the Bank employs
attorneys or incurs other expenses for the collection of amounts due hereunder or the enforcement
of performance or observance of any obligation or agreement on the part of the Lessee herein
contained, the Lessee agrees that it will on demand therefor pay to the Bank the fees of such
attorneys and such other expenses so incurred by the Bank.

     Section 8.5 Waiver of Event of Default; No Additional Waiver Implied by One Waiver.
The Bank in its sole discretion may waive an Event of Default, provided that either (a) notice of
the occurrence of an Event of Default has not yet been given to the Trustee, or (b) following such
Event of Default, a drawing under the Letters of Credit is not required to be made by the Trustee
in accordance with Section 9.2 of the Indenture.

     In the event any agreement contained in this Reimbursement Agreement is breached by the Lessee
and thereafter waived (expressly or impliedly) by the Bank, such waiver shall be limited to the
particular breach so waived and shall not be deemed to waive any other breach hereunder. Any
forbearance (expressly or impliedly) by the Bank to demand payment for any amounts payable
hereunder shall be limited to the particular payment for which the Bank forebears demand for
payment and will not be deemed a forbearance to demand any other amount payable hereunder.

ARTICLE IX

MISCELLANEOUS

     Section 9.1 Notices. Except as otherwise provided in this Reimbursement Agreement,
all notices, demands, requests, consents, approvals, certificates or other communications required
under this Reimbursement Agreement to be in writing shall be sufficiently given and shall be deemed
to have been properly given (i) if delivered by hand, when written confirmation of delivery is
received by the sender, (ii) three days after the same is mailed by certified mail, postage
prepaid, return receipt requested, or (iii) if sent by overnight courier, 24 hours after delivery
to such overnight courier, addressed to the person to whom any such notice, demand, request,
approval, certificate or other communication is to be given, at the appropriate address for the
Principal Office of such person designated below:

	 	 	 
	Bank:

	 	Manufacturers and Traders Trust Company
	 

	 	25 South Charles Street, 11th Floor
	 

	 	Baltimore, Maryland 21201
	 

	 	Attention: Letter of Credit Department
	 
	 	 
	 

	 	and

22

 

	 	 	 
	 

	 	Manufacturers and Traders Trust Company
	 

	 	1 Research Court, Suite 400
	 

	 	Rockville, Maryland 20850
	 

	 	Attention: Arthur L. Perraud
	 
	 	 
	 

	 	with a copy to:
	 
	 	 
	 

	 	Nancy R. Little, Esquire
	 

	 	McGuireWoods LLP
	 

	 	One James Center
	 

	 	901 East Cary Street
	 

	 	Richmond, Virginia 23219
	 
	 	 
	Lessee:

	 	Human Genome Sciences, Inc.
	 

	 	14200 Shady Grove Road
	 

	 	Rockville, Maryland 20850
	 

	 	Attention: James H. Davis, Executive
	 

	 	Vice President, General Counsel
	 

	 	and Secretary

Any person listed above may, by notice given hereunder, designate any further or different
addresses to which subsequent communications shall be sent. During any period in which the
Registrar and the Paying Agent are the same and have the same address, any notice required to be
given to either the Registrar or the Paying Agent, or both, may be given by one notice to the
address for the Registrar and Paying Agent set forth above.

     Section 9.2 [INTENTIONALLY OMITTED].

     Section 9.3 [INTENTIONALLY OMITTED].

     Section 9.4 Binding Effect. This Reimbursement Agreement shall inure to the benefit
of and shall be binding upon the Bank, the Lessee and their respective successors and assigns.

     Section 9.5 Illegality; Severability. If fulfillment of any provision hereof or any
transaction related hereto or to the Letter of Credit Documents, at the time performance of such
provisions shall be due, shall involve transcending the limit of validity prescribed by law, then
ipso facto, the obligation to be fulfilled shall be reduced to the limit of such validity; and if
any clause or provisions herein contained, operates or would prospectively operate to invalidate
this Reimbursement Agreement in whole or in part, then such clause or provision only shall be void,
as though not herein contained, and the remainder of this Reimbursement Agreement shall remain
operative and in full force and effect.

     Section 9.6 Assignment. None of the Letter of Credit Documents to which the Lessee is
a party may be assigned by the Lessee unless otherwise expressly permitted by the terms thereof.
The Bank may at any time sell or grant participations to any other Person (a

23

 

“participant”) in the Issuer’s Letter of Credit Obligations and the Letter of Credit
Documents; provided, however, except as provided in the immediately following sentence, the Lessee
shall continue to deal solely and directly with the Bank in connection with the Bank’s rights and
remedies under this Reimbursement Agreement. The Lessee hereby authorizes the Bank and each such
participant, in case of an Event of Default hereunder, to proceed directly, by right of setoff,
banker’s lien or otherwise, against any assets of the Lessee which may at the time of such default
be in the hands of the Bank or in the hands of such participant.

     Section 9.7 Consent to Jurisdiction; Service of Process; Waiver of Jury Trial.

          (a) The Lessee hereby agrees and consents that any action or proceeding arising out of or
brought to enforce the provisions of this Reimbursement Agreement may be brought in any appropriate
court in Montgomery County, Maryland or Baltimore City, Maryland, all at the sole election of the
Bank, and by the execution of this Reimbursement Agreement the Lessee irrevocably consents to the
jurisdiction of each such court.

          (b) If for any reason the Lessee should become not qualified to do business in the State, the
Lessee hereby agrees to designate and appoint, without power of revocation, an agent for service of
process within the State, as the agent for the Lessee upon whom may be served all process,
pleadings, notice or other papers which may be served upon the Lessee as a result of any of the
Lessee’s obligations under this Reimbursement Agreement.

          (c) The Lessee covenants that throughout the period during which any of the Lessee’s
obligations under this Reimbursement Agreement remain outstanding, if a new agent for service of
process within the State is designated pursuant to the terms of subsection (b) of this Section, the
Lessee will immediately file with the Bank the name and address of such new agent and the date on
which such appointment is to become effective.

          (d) The Lessee and the Bank hereby jointly waive trial by jury in any action or proceeding to
which the Lessee and the Bank may be parties, arising out of or in any way pertaining to this
Reimbursement Agreement or any of the Letter of Credit Documents. It is agreed and understood that
this waiver constitutes a waiver of trial by jury of all claims against all parties to such actions
or proceedings who are parties to the Letter of Credit Documents and the Bond Documents.

     This waiver is knowingly, willingly and voluntarily made by the Lessee, and the Lessee hereby
represents that no representations of fact or opinion have been made by any individual to induce
this waiver of trial by jury or to in any way modify or nullify its effect. The Lessee further
represents that it has been represented in the signing of this Reimbursement Agreement and in the
making of this waiver by independent legal counsel, selected of its own free will, and that it has
had the opportunity to discuss this waiver with counsel.

     Section 9.8 Further Assurances and Corrective Instruments. The Bank and the Lessee
agree that they will, from time to time, execute and deliver or cause to be executed and delivered,
such supplements hereto and such further instruments as may reasonably be required for carrying out
the intention of the parties to, or facilitating the performance of, this Reimbursement Agreement.

24

 

     Section 9.9 Right to Perform; Advances by Bank. If the Lessee fails to make or cause
to be made any payment, or fails to perform, observe or comply with any of the Lessee’s obligations
under this Reimbursement Agreement, the Bank, without notice to the Lessee and without waiving any
default or releasing the Lessee from any of the Lessee’s obligations under this Reimbursement
Agreement, and without being under any obligation to do so, may make such payment or perform any of
the Lessee’s obligations under this Reimbursement Agreement for the account of the Lessee, and may
enter upon the Property or any part thereof for that purpose and take all such action thereon as
the Bank may consider necessary or appropriate for such purpose. All amounts so paid by the Bank
and all costs, fees and expenses incurred by the Bank in connection with such payment or
performance (including, without limitation, attorneys’ fees and expenses) shall be immediately due
and payable by the Lessee as additional payments, together with interest thereon from the date the
same are paid or incurred at the Penalty Rate until the same are paid in full by the Lessee.

     Section 9.10 Amendments, Changes and Modifications. This Reimbursement Agreement may
not be amended, changed, modified, altered or terminated except by a written instrument executed by
the Bank and the Lessee.

     Section 9.11 Execution of Counterparts. This Reimbursement Agreement may be executed
in several counterparts, each of which shall be an original and all of which shall constitute but
one and the same instrument.

     Section 9.12 Law Governing Construction of Agreement. This Reimbursement Agreement is
prepared and entered into with the intention that the law of the State shall govern its
construction.

     Section 9.13 Effective Date. This Reimbursement Agreement has been dated as of the
date above written solely for the purpose of convenience of reference and shall become effective
upon its execution and delivery, on the date hereof, by the parties hereto. All representations
and warranties set forth herein shall be deemed to have been made on the date hereof.

     Section 9.14 Conflicting Agreements. In the event of any conflict between the
provisions of the Letter of Credit Documents and this Reimbursement Agreement regarding the payment
and performance obligations of the Lessee, the provisions of this Reimbursement Agreement shall
control as between the Bank and the Lessee.

     Section 9.15 Set-off. In addition to any rights now or hereafter granted under
applicable law and not by way of limitation of any such rights, during the continuance of any Event
of Default hereunder, the Bank is hereby authorized at any time and from time to time, without
notice to the Lessee or to any other person or entity, any such notice being hereby expressly
waived, to set-off and to appropriate and apply any and all deposits and any other indebtedness at
any time held or owing by the Bank to or for the credit or the account of the Lessee against and on
account of the obligations and liabilities of the Lessee to the Bank under this Reimbursement
Agreement, irrespective of whether or not the Bank shall have made any demand hereunder.

25

 

     IN WITNESS WHEREOF, the Lessee has caused this Reimbursement Agreement to be executed under
seal in its name and on its behalf by its duly authorized officer; and the Bank has caused this
Reimbursement Agreement to be executed under seal by its duly authorized officer, all being done as
of the day and year first above written.

	 	 	 	 	 	 
	WITNESS:	 	HUMAN GENOME SCIENCES, INC., as Lessee

 	 
	 	 	By:  	/s/
H. Thomas Watkins	(SEAL)
	 	 	 	Name:  	H. Thomas Watkins	 	 
	 	 	 	Title:  	President
and Chief Executive Officer	 	 
	 	 
	WITNESS:	 	MANUFACTURERS AND TRADERS TRUST

COMPANY, as Bank

 	 
	 	 	By:  	/s/
Arthur L. Perraud	(SEAL)
	 	 	 	Name:  	Arthur L. Perraud	 	 
	 	 	 	Title:  	Vice
President	 	 
	 	 

26exv10w14

Exhibit 10.14

COLLATERAL PLEDGE AGREEMENT

among

HUMAN GENOME SCIENCES, INC.,

as Pledgor,

MANUFACTURERS AND TRADERS TRUST COMPANY,

as Pledgee

and

MANUFACTURERS AND TRADERS TRUST COMPANY,

acting in its capacity as Collateral Agent

Dated as of December 1, 2009

$23,000,000

Maryland Economic Development Corporation

Taxable Variable Rate Demand/Fixed Rate Revenue Bonds

(Human Genome Sciences, Inc. Facility)

1997 Issue

and

$17,500,000

Maryland Economic Development Corporation

Taxable Variable Rate Demand/Fixed Rate Revenue Bonds

(Human Genome Sciences, Inc. Facility)

Series 1999 A and B

 

 

 

COLLATERAL PLEDGE AGREEMENT

     THIS COLLATERAL PLEDGE AGREEMENT (this “Agreement”) is dated as of December 1, 2009, and is
among HUMAN GENOME SCIENCES, INC., a Delaware corporation (the “Pledgor”), MANUFACTURERS AND
TRADERS TRUST COMPANY, a New York banking corporation (the “Pledgee”), and MANUFACTURERS AND
TRADERS TRUST COMPANY, a New York banking corporation, acting in its capacity as Collateral Agent
(the “Collateral Agent”).

RECITALS

     Pursuant to, and in accordance with the provisions of Article 83A, Title 5, Subtitle 2 of the
Annotated Code of Maryland, as amended from time to time (the “Act”), the Maryland Economic
Development Corporation, a body politic and corporate and a public instrumentality of the State of
Maryland (the “Issuer”) issued and sold its Taxable Variable Rate Demand/Fixed Rate Revenue Bonds
(Human Genome Sciences, Inc. Facility), 1997 Issue, in the aggregate principal amount of
$23,000,000 (the “1997 Bonds”) for the sole and exclusive purpose of financing a portion of (1) the
acquisition of approximately 10 acres of land located in Montgomery County, Maryland (the “Land”)
and (2) the construction of a process development and manufacturing plant on the Land containing
approximately 84,000 square feet (the “Building”). The Land and the Building are collectively
referred to as the “Facility.” The Issuer currently leases the Facility to the Pledgor pursuant
to a Lease Agreement dated as of December 1, 1997, as amended or supplemented from time to time.

     The 1997 Bonds were issued pursuant to a Trust Indenture dated as of December 1, 1997, by and
between the Issuer and FMB Trust Company, National Association (now known as Manufacturers and
Traders Trust Company) (the “Trustee”).

     In order to enhance the marketability of the 1997 Bonds, at the request of the Issuer and the
Lessee, Allfirst Bank (“Allfirst”), predecessor in interest to the Pledgee, issued to the Trustee
Allfirst’s irrevocable transferable direct-pay letter of credit to provide payment for and secure
the payment of the principal of and interest on, and the purchase price of, the 1997 Bonds (the
“1997 Bonds Letter of Credit”).

     Pursuant to, and in accordance with the Act, the Issuer subsequently issued and sold its
Taxable Variable Rate Demand/Fixed Rate Revenue Bonds (Human Genome Sciences, Inc. Facility)
Series 1999 A and B, in the aggregate principal amount of $17,500,000 (the “1999 Bonds”) for the
sole and exclusive purpose of financing a portion of the costs of improving and equipping a 43,000
square-foot (approximate) addition to the Building (the “Additional Improvements”). The Issuer
currently leases the Additional Improvements to the Pledgor pursuant to an Amended and Restated
Lease Agreement of even date herewith.

     The 1999 Bonds were issued pursuant to a Trust Indenture dated as of December 1, 1999, by and
between the Issuer and the Trustee’s predecessor in interest, Allfirst Trust Company, National
Association, which Trust Indenture has subsequently been amended and restated in its entirety
pursuant to an Amended and Restated Trust Indenture of even date herewith.

 

 

     In order to enhance the marketability of the Series 1999 A Bonds, at the request of the Issuer
and the Pledgor, Allfirst issued to the Trustee Allfirst’s irrevocable transferable direct-pay
letter of credit to provide payment for and secure the payment of the principal of and interest on,
and the purchase price of, the Series 1999 A Bonds (the “Series 1999 A Bonds Letter of Credit”).

     In order to enhance the marketability of the Series 1999 B Bonds, at the request of the Issuer
and the Pledgor, First Union National Bank (“First Union”) issued to the Trustee First Union’s
irrevocable transferable direct-pay letter of credit to provide payment for and secure the payment
of the principal of and interest on, and the purchase price of, the Series 1999 B Bonds (the “First
Union Series 1999 B Bonds Letter of Credit”).

     The 1997 Bonds Letter of Credit, the Series 1999 A Bonds Letter of Credit and the First Union
Series 1999 B Bonds Letter of Credit each expire on December 15, 2009.

     At the request of the Issuer and the Pledgor, the Pledgee, as successor in interest to
Allfirst, has agreed to extend the 1997 Bonds Letter of Credit and the Series 1999 A Bonds Letter
of Credit.

     At the request of the Issuer and the Pledgor, in substitution for the First Union Series 1999
B Bonds Letter of Credit, the Pledgee has agreed to issue the Pledgee’s irrevocable transferrable
direct-pay letter of credit to provide payment for and secure the payment of the principal of and
interest on, and the purchase price of, the Series 1999 B Bonds (the “Substitute Series 1999 B
Bonds Letter of Credit”).

     As a condition precedent to the extension of the 1997 Bonds Letter of Credit, the Pledgee has
required that the Pledgor enter into a Reimbursement Agreement of even date herewith pursuant to
which the Pledgor has agreed to reimburse the Pledgee for any draws made under the 1997 Bonds
Letter of Credit and for certain other items set forth therein (as amended or supplemented from
time to time, the “1997 Reimbursement Agreement”).

     As a condition precedent to the extension of the Series 1999 A Bonds Letter of Credit and the
issuance of the Substitute Series 1999 B Bonds Letter of Credit, the Pledgee has required that the
Pledgor enter into a Reimbursement Agreement of even date herewith pursuant to which the Pledgor
has agreed to reimburse the Pledgee for any draws made under the Series 1999 A Bonds Letter of
Credit and/or the Substitute Series 1999 B Bonds Letter of Credit and for certain other items set
forth therein (as amended or supplemented from time to time, the “1999 Reimbursement Agreement”
and, together with the 1997 Reimbursement Agreement, the “Reimbursement Agreements”).

     In order to secure the Pledgor’s obligations under the Reimbursement Agreements, the Pledgee
requires that the Pledgor post cash collateral and/or securities with a minimum market value of
$34,300,000 (the “Minimum Collateral Amount”).

     NOW, THEREFORE, in order to secure its obligations under the Reimbursement Agreements, the
Pledgor hereby covenants and agrees with the Pledgee as follows:

 

 

     1. Grant of Security Interest; Custody; Perfection. The Pledgor hereby pledges,
assigns and grants to the Pledgee a security interest in the cash and marketable securities on
deposit in the account maintained by the Pledgor with the Collateral Agent as described in
Exhibit A attached hereto and made a part hereof (the “Account”), the Account, and all
interest and other income thereon and all cash and noncash proceeds thereof (all of the foregoing
is herein collectively referred to as the “Collateral”) pursuant to the provisions of the Maryland
Uniform Commercial Code, in order to secure the Pledgor’s obligations under the Reimbursement
Agreements.

     The Collateral is to be held by the Collateral Agent on behalf of the Pledgee. The Pledgor
hereby agrees that the Pledgee shall have with respect to the Collateral the rights and remedies of
a secured party provided in the Maryland Uniform Commercial Code. The Collateral Agent will at all
times maintain the Account at its offices in the State of Maryland.

     As of the effective date of this Agreement, the Pledgor has pledged, assigned and granted to
the Pledgee a security interest in the Collateral and such Collateral and the Account have been
designated on the records of the Collateral Agent as subject to the security interest granted
pursuant to this Agreement in accordance with the provisions of the Maryland Uniform Commercial
Code. The Pledgor and the Collateral Agent hereby agree that all securities or other property
underlying any financial assets credited to the Account shall be registered in the name of the
Collateral Agent, endorsed to the Collateral Agent or in blank or credited to another securities
account maintained in the name of the Collateral Agent and in no case will any financial asset
credited to the Account be registered in the name of the Pledgor, payable to the order of the
Pledgor or specially indorsed to the Pledgor.

     The Collateral Agent hereby agrees that all property delivered to the Collateral Agent with
respect to the pledge and security intended hereby will be held in or credited to the Account. The
Collateral Agent further agrees that each item of property (including, without limitation, any
investment property, financial asset, security, instrument, general intangible or cash) credited to
the Account shall be treated as a “financial asset” within the meaning of Section 8-102(a)(9) of
the Maryland Uniform Commercial Code.

     The Pledgor hereby directs the Collateral Agent, and the Collateral Agent hereby agrees, to
comply with all entitlement orders of the Pledgee with respect to the Collateral and the Account
without further consent of the Pledgor.

     3. Minimum Collateral Value. The Pledgor shall maintain on deposit, in the Account,
Collateral with an actual market value of not less than the Minimum Collateral Amount, taking into
account any penalties, fees, discounts or other amounts that could result in any reduction in the
actual cash value of any of the Collateral upon any liquidation or early termination of any
investments prior to the maturity date thereof.

     4. Investment; Preservation of Collateral. Funds held by the Collateral Agent
hereunder shall be invested and reinvested by the Collateral Agent upon written order of the
Pledgor only in Permitted Investments as described in Exhibit B attached hereto and made a
part hereof. Such investments shall be registered in the name of the Collateral Agent and held by
the Collateral Agent for the benefit of the Pledgee. The Collateral Agent shall not be responsible
or

 

 

liable for any loss suffered in connection with any investment of moneys made by it in
accordance with the Pledgor’s instruction.

     The Pledgor shall be responsible for the preservation of the Collateral in the Collateral
Agent’s possession and shall take all action necessary to preserve the rights of the Pledgee
against prior parties to the Collateral. Neither the Pledgee nor the Collateral Agent shall be
under any duty (a) to collect any of the Collateral or any moneys due or to become due thereunder,
(b) to give any notices with respect to the Collateral, (c) to preserve or maintain any of the
Collateral not in its possession, or (d) to preserve rights of the Pledgor against prior parties to
the Collateral. The Pledgee and the Collateral Agent shall be deemed to have exercised reasonable
care with respect to any of the Collateral in their possession if the Pledgee or the Collateral
Agent takes such action for that purpose as the Pledgor shall reasonably request in writing;
provided, however, that no failure to comply with any such request shall, of itself, be deemed a
failure to exercise reasonable care, and no failure to do any act not requested by the Pledgor
shall be deemed a failure to exercise reasonable care.

     5. Pledgor’s Representations and Warranties and Covenants. The Pledgor represents and
warrants and covenants that:

	 	(i)	 	it has received value (as defined in Section 1-201 (44) of the Maryland Uniform
Commercial Code),
	 
	 	(ii)	 	it has the right to create a security interest in the Collateral,
	 
	 	(iii)	 	the Collateral is not subject to the interest of any third person,
	 
	 	(iv)	 	the Pledgor will defend the Collateral against the claims and demands of all
third parties,
	 
	 	(v)	 	all statements provided by Pledgor relating to the Collateral relied upon by
the Pledgee prior to, contemporaneous with or subsequent to execution of this Agreement
are or shall be true, correct, complete, valid and genuine in all material respects,
	 
	 	(vi)	 	it has taken or caused other persons to take all actions necessary to effect
the creation and perfection of the Pledgee’s security interest in the Collateral, and
has caused to be filed with the Maryland State Department of Assessments and Taxation,
the Secretary of State of the jurisdiction of organization of the Pledgor, and, if the
Account is maintained in a different jurisdiction, the Secretary of State of the
jurisdiction in which the Account is maintained, UCC-1 financing statements naming the
Pledgor as debtor and the Pledgee as a secured party and evidencing the lien or pledge
created by this Agreement, and, together with the book entries described above, such
actions taken with respect to the Collateral pursuant to this Agreement create a valid
and perfected first priority security interest in the Collateral, pursuant to the
Maryland Uniform Commercial Code,
	 
	 	(vii)	 	it has full power, authority and legal right to enter into this Agreement and
to pledge and grant a lien on the Collateral pursuant to this Agreement, and this
Agreement has been duly authorized, executed and delivered by Pledgor and constitutes
the legal, valid and binding obligation of Pledgor, enforceable against Pledgor in
accordance with its terms,
	 
	 	(viii)	 	no authorization, consent, approval, license, qualification or formal exemption from,
nor any filing, declaration or registration with, any court, governmental

 

 

	 	 	 	authority, or with any securities exchange is required in connection with (A) the
due execution, delivery or performance by Pledgor of this Agreement, (B) the
assignment of, and the grant of a lien on (including priority thereof), the
Collateral by Pledgor in the manner and for the purpose contemplated by this
Agreement, or (C) the exercise of the rights and remedies of Pledgee created hereby
except those that have been obtained or made concurrently with the execution hereof,
including, without limitation, filings in the appropriate offices under the Maryland
Uniform Commercial Code,
	 
	 	(ix)	 	Neither the execution and delivery of this Agreement, nor the consummation of
the transactions herein contemplated, nor compliance with the terms and provisions
hereof will conflict with or result in a breach of, Pledgor’s formation agreements, any
applicable law or regulation, or any order, writ, injunction or decree of any court or
governmental authority binding on Pledgor, or any agreement or instrument to which
Pledgor is a party or by which Pledgor is bound or to which any of the Collateral is
subject, or result in the creation or imposition of any lien upon Pledgor’s earnings or
assets pursuant to the terms of any such agreement or instrument,
	 
	 	(x)	 	the pledge of the Collateral to the Pledgee is not done in contemplation of
insolvency or bankruptcy or with an intent to hinder, delay or defraud any of Pledgor’s
creditors,
	 
	 	(xi)	 	it is not insolvent immediately before signing this Agreement and is not being
rendered insolvent by the pledge of the Collateral to the Pledgee, and
	 
	 	(xii)	 	it will not pledge, assign or grant a security interest in the Collateral to
any person other than the Pledgee.

     6. Partial Release of Collateral. Provided no Event of Default under this Agreement
has occurred and is continuing, when the actual market value of the Collateral exceeds the Minimum
Collateral Amount, the Pledgor shall have the right to request that the Pledgee release from the
security interest granted pursuant to this Agreement Collateral in an amount equal to such excess;
provided, however, the Pledgor shall not have the right to request such a release more than one
time in any quarter. In the event that the Pledgor shall request that the Pledgee release
Collateral from the security interest granted pursuant to this Agreement, the Pledgee shall not
liquidate any Collateral for purposes of honoring such request without the prior written consent of
the Pledgor.

     7. Deposits to Account. If at any time the actual market value of the Collateral is
less than the Minimum Collateral Amount, the Pledgor shall within two (2) business days deposit to
the Account and designate on the records of the Collateral Agent as subject to the security
interest granted pursuant to this Agreement cash or marketable securities in an amount equal to the
difference, between (a) the Minimum Collateral Amount, and (b) the actual market value of the
Collateral. The Collateral Agent shall notify the Pledgor in writing of the amount to be deposited
hereunder and the Pledgor shall promptly provide the Pledgee with evidence reasonably satisfactory
to the Pledgee that such deposit has been made.

     Other than with respect to reporting requirements regarding the Collateral, the Collateral
Agent shall have no obligations or responsibilities hereunder to any parties hereto with respect to
any accounts of the Pledgor other than the Account. Notwithstanding the foregoing, however,

 

 

nothing herein provided shall abrogate the Collateral Agent’s responsibilities to the Pledgor
with respect to any other accounts managed or held by the Collateral Agent for or on behalf of the
Pledgor.

     8. Substitutions. Provided no Event of Default under this Agreement has occurred and
is continuing, the Pledgor may at any time and from time to time substitute cash and marketable
securities for the Collateral on deposit in the Account; provided, however, the actual market value
of the Collateral shall at all times be equal to or greater than the Minimum Collateral Amount.

     9. Investment Earnings. Provided no Event of Default under this Agreement has
occurred and is continuing, when the actual market value of the Collateral equals at least Minimum
Collateral Amount, investment earnings on the Collateral shall, on the last day of each quarter
thereafter, be distributed to the Pledgor. In connection with the distribution of any investment
earnings on the Collateral pursuant to this Paragraph 9, the Pledgee shall not liquidate any
Collateral for purposes of making such distribution without the prior written consent of the
Pledgor.

     10. Reporting Requirements. Not more than five (5) business days following the end of
each calendar month, the Collateral Agent shall furnish to the Pledgee and the Pledgor a statement
of the actual market value of the Collateral on deposit in the Account.

     11. Authority Over Account; Limitations on Withdrawals. The Pledgee shall have sole
authority over withdrawals of the Collateral from the Account and no withdrawal of the Collateral
from the Account shall be made except upon the written instructions of the Pledgee signed by an
authorized officer of the Pledgee; provided, however, such withdrawals shall only be permitted when
there is an Event of Default pursuant to this Agreement or when the Pledgee is releasing excess
funds pursuant to Paragraphs 6, 8 or 9 hereof. Any written instructions from the Pledgee shall
permit withdrawals within two (2) business days from the date thereof. In relying upon such written
instructions from the Pledgee, the Collateral Agent shall have no liability other than for its
negligence or willful misconduct.

     12. Default; Remedies Upon Default. The occurrence of any one or more of the
following events shall constitute an Event of Default under this Agreement: (a) an event of
default under either of the Reimbursement Agreements; or (b) failure of the Pledgor to perform,
observe, or comply with any of the provisions of this Agreement, and such failure shall remain
uncured for a period of five (5) days in the event of a monetary default and thirty (30) days in
the event of a non-monetary default after the date of written notice from the Pledgee to the
Pledgor. The Pledgee shall contemporaneously give the Collateral Agent and the Pledgor written
notice of an Event of Default hereunder and the Collateral Agent shall from receipt of such notice
act only upon the instructions of the Pledgee and the Collateral Agent shall have no liability to
the Pledgor in following such instructions.

     Upon an Event of Default under this Agreement that has not been waived by the Pledgee, and any
time thereafter, the Pledgee may, among its other rights and remedies (1) cause the Collateral to
be transferred to its name or to the name of its nominee or nominees and thereafter exercise as to
the Collateral all rights, powers and remedies of an owner, (2) collect by legal

 

 

proceedings or otherwise all dividends, interest, principal payments, and other sums now or
hereafter payable on account of the Collateral, and hold the same as Collateral, or apply the same
to the expenses incurred by the Pledgee in such legal proceedings, the manner and distribution of
the application to be in the sole discretion of the Pledgee, (3) enter into any extension,
subordination, reorganization, deposit, merger, or consolidation agreement, or any other agreement
relating to or affecting the Collateral and in connection therewith deposit or surrender control of
such Collateral thereunder, and accept other property in exchange therefor and hold or apply such
property or money so received in accordance with the provisions hereof, all of the foregoing
specified rights and remedies, however, being subject to the rights of the Pledgor provided in the
Maryland Uniform Commercial Code. The Pledgee shall give written notice to the Pledgor ten (10)
days prior to the date of public sale of the Collateral or prior to the date after which private
sale of the Collateral will be made.

     Subject to compliance with federal and state securities laws, full power and authority are
hereby given to the Pledgee, acting through any of its respective officers, upon an Event of
Default hereunder that has not been waived by the Pledgee, and at any time thereafter, at its
election, to sell, assign, transfer and deliver the whole of the Collateral, or any part thereof or
any additions thereto, or substitutes therefor, in such order as the Pledgee may elect, at public
or private sale.

     To the extent the Pledgee actually receives any monies as a result of its exercise of any of
the remedies provided for hereunder following the occurrence of an Event of Default hereunder, the
Pledgee covenants and agrees that such monies, after deducting all costs incurred by the Pledgee in
connection with the collection thereof, shall be credited against the obligations of the Pledgor
under the Reimbursement Agreements in such order as the Pledgee in its discretion may determine.

     No failure or delay by the Pledgee to insist upon the strict performance of any term,
condition, covenant, or agreement of this Agreement or of the Reimbursement Agreements, or to
exercise any right, power, or remedy consequent upon a breach thereof, shall constitute a waiver of
any such term, condition, covenant, or amendment or of any such breach, or preclude the Pledgee
from exercising any such right, power, or remedy at any later time or times. By accepting payment
after the due date of any of the obligations under this Agreement or of the Reimbursement
Agreements, the Pledgee shall not be deemed to have waived the right either to require prompt
payment when due of all other such obligations or to declare a default for failure to effect such
payment of any such other obligations.

     Each right, power, and remedy of the Pledgee as provided for in this Agreement or in the
Reimbursement Agreements or now or hereafter existing at law or in equity or by statute or
otherwise shall be cumulative and concurrent and shall be in addition to every other right, power,
or remedy provided for in this Agreement or in the Reimbursement Agreements or now or hereafter
existing at law or in equity or by statute or otherwise, and the exercise or beginning of the
exercise by the Pledgee of any one or more of such rights, powers, or remedies shall not preclude
the simultaneous or later exercise by the Pledgee of any or all such other rights, powers, or
remedies.

 

 

     13. Costs and Expenses. All reasonable costs and expenses, including reasonable
attorney’s fees and expenses, incurred or paid by the Pledgee in exercising any right, power or
remedy conferred hereby, and in the endorsements thereof, shall become a part of the indebtedness
or obligations secured hereby.

     14. Further Assurances. The Pledgor shall, at its expense, do, make, procure, execute
and deliver all acts, things, writings and assurances as the Pledgee may at any time request to
protect, assure or enforce its interest, rights and remedies created by, provided in or emanating
from this Agreement.

     15. Release, Indulgences, etc. The Pledgor agrees that demand, notice, protest and
all demands and notices of any action taken by the Pledgee under this Agreement, except those
expressly provided for in this Agreement and the Reimbursement Agreements, are hereby waived.
Without notice to and further consent from the Pledgor, without in any way waiving any of the
provisions of this Agreement, and without in any way releasing all or any part of the Pledgor’s
obligations under this Agreement or in the Collateral, the Pledgor hereby consents: (a) to any
extension of time for payment of any of the obligations of the Pledgor under the Reimbursement
Agreements; (b) to any renewal, modification, waiver, or release of, any of the obligations of the
Pledgor under the Reimbursement Agreements; (c) to the addition to, or release of the Pledgor or of
any other maker, accommodation party, endorser, guarantor, surety, or indemnitor from, any of their
respective obligations under the Reimbursement Agreements; (d) to the addition to, or release of,
all or any part of the collateral and security for the Reimbursement Agreements and all or any part
of Collateral hereunder; (e) to any indulgence and/or waiver given to the Pledgor or to any other
maker, accommodation party, endorser, guarantor, surety, or indemnitor of any of the obligations of
the Pledgor under the Reimbursement Agreements.

     16. Liability, Duties, and Resignation of Collateral Agent.

          (a) The Collateral Agent shall hold the Collateral as agent for the Pledgee. The Collateral
Agent agrees to send a written confirmation to the Pledgee that it is holding the Collateral and
the Account for the sole and exclusive account of the Pledgee for the benefit of the Pledgee.

          (b) The Collateral Agent, its affiliates, directors and officers and its respective
successors, assigns, agents and servants, absent negligence or willful misconduct, shall not be
held to any personal liability whatsoever, in tort, contract or otherwise, in connection with the
execution and delivery of, or performance of its obligations under, this Agreement.

          (c) This Agreement sets forth exclusively the duties of the Collateral Agent with respect to
any and all matters pertinent hereto and no implied duties or obligations shall be read into this
Agreement against the Collateral Agent. The Collateral Agent may act in reliance upon any
instrument or signature believed by it to be genuine and may assume that any person purporting to
give any writing, notice, advice or direction for or on behalf of the Pledgee in connection with
the provisions hereof has been duly authorized to do so.

 

 

          (d) The Collateral Agent may resign from its obligations under this Agreement at any time
after thirty (30) days’ prior written notice to the other parties hereto, but in no event shall
Collateral Agent be released of its obligations hereunder unless and until a substitute eligible
institution has been designated and has assumed in writing the obligations of Collateral Agent
hereunder.

     17. Notices. All notices, demands, requests, consents, approvals, certificate or
other communications required under this Agreement to be in writing shall be sufficiently given and
shall be deemed to have been properly given (i) if delivered by hand, when written confirmation of
delivery is received by the sender, (ii) three days after the same is mailed by certified mail,
postage prepaid, return receipt requested, or (iii) if sent by overnight courier, 24 hours after
delivery to such overnight courier, addressed to the person to whom any such notice, demand,
request, approval, certificate or other communication is to be given, at the appropriate address of
such person as designated below:

	 	 	 
	If to the Pledgor at:

	 	Human Genome Sciences, Inc.
	 

	 	14200 Shady Grove Road
	 

	 	Rockville, Maryland 20850
	 

	 	Attention: James H. Davis, Executive Vice President,
	 

	 	           General Counsel and Secretary
	 

	 	Tel: (301) 251-6039
	 

	 	Fax: (301) 517-8831
	 
	 	 
	If to the Pledgee at:

	 	Manufacturers and Traders Trust Company
	 

	 	1 Research Court, Suite 400
	 

	 	Rockville, Maryland 20850
	 

	 	Attention: Arthur L. Perraud
	 

	 	           Senior Relationship Manager
	 

	 	Tel: (240) 632-7808
	 

	 	Fax: (240) 632-2621
	 
	 	 
	If to the Collateral
Agent at:

	 	Manufacturers and Traders Trust Company
	 

	 	25 South Charles Street, 16th Floor
	 

	 	Mail Code MD2-CS58
	 

	 	Baltimore, Maryland 21201
	 

	 	Attention: Sabrina Thomas
	 

	 	Tel: (410) 545-2193
	 

	 	Fax: (410) 244-4236

     18. Miscellaneous. Neither this Agreement nor any term, condition, covenant, or
agreement hereof may be changed, waived, discharged, or terminated orally, but only by an
instrument in writing signed by the party against whom enforcement of the change, waiver,
discharge, or termination is sought. This Agreement shall be governed by the laws of the State of
Maryland and shall be binding upon the successors and assigns of the Pledgor and shall inure to
the benefit of the Pledgee and its respective successors and assigns. As used herein, the singular
number shall include the plural, and the use of the masculine, feminine, or neuter gender shall
include all genders as the context may require, and the term “person” shall include an

 

 

individual, a corporation, an association, a partnership, a trust, a limited liability
company, an organization, a government or political subdivision thereof, and a governmental agency.
Headings and captions used in this Agreement are solely for convenience of reference and shall not
affect the meaning of this Agreement. Unless varied by this Agreement, all terms used herein which
are defined by the Maryland Uniform Commercial Code shall have the same meanings hereunder as
assigned to them by the Maryland Uniform Commercial Code. This Agreement may be executed in several
counterparts, each of which shall be an original and all of which shall constitute one and the same

     19. Termination. This Agreement shall terminate when 1997 Bonds Letter of Credit, the
Series 1999 A Bonds Letter of Credit and the Substitute Series 1999 B Bonds Letter of Credit
terminate and all obligations under the Reimbursement Agreements have been indefeasibly paid and
performed in full, and upon the termination of this Agreement, the Pledgee shall instruct the
Collateral Agent to reassign to the Pledgor, without recourse or warranty, express or implied, the
then existing rights, title and interest of the Pledgee in and to the Collateral, the costs of such
reassignment to be borne by the Pledgor.

(SIGNATURES APPEAR ON FOLLOWING PAGE)

 

 

     WITNESS the signature and seal of the Parties as of the date first written above.

	 	 	 	 	 	 	 
	WITNESS:	 	HUMAN GENOME SCIENCES, INC.,

as Pledgor
	 
	 	 	 	 	 	 
	 

	 	By:	/s/ H. Thomas Watkins	 	(SEAL) 
	 

	 	 	 	 	 
	 

	 	 	Name:	 H. Thomas Watkins	 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	Title:
	President and Chief Executive
Officer
	 	 
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	WITNESS:	 	MANUFACTURERS AND TRADERS TRUST,

COMPANY, as Pledgee
	 
	 	 	 	 	 	 
	 

	 	By:
	 /s/ Arthur L. Perraud	 	(SEAL)
	 

	 	 	 	 	 
	 

	 	 	Name:	 Arthur L. Perraud	 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	Title:	Vice President	 	 	 
	 

	 	 	 	 	 	 
	WITNESS:	 	MANUFACTURERS AND TRADERS TRUST 
COMPANY, as Collateral
Agent
	 
	 	 	 	 	 	 
	 

	 	By:
	/s/ Cassandra J. Cole	 	(SEAL)
	 

	 	 	 	 	 
	 

	 	 	Name:	 Cassandra J. Cole	 	 	 
	 

	 	 	 	 	 	 
	 

	 	 	Title:	Vice President	 	 	 
	 

	 	 	 	 	 	 

 

 

Exhibit A to

Collateral Pledge Agreement

DESCRIPTION OF ACCOUNT

	 	 	 	 	 	 	 
	Account Owner	 	Account Name	 	Account Number
	Human Genome Sciences
	 	 

 

 

Exhibit B to

Collateral Pledge Agreement

PERMITTED INVESTMENTS

     The term “Permitted Investments” as used in this Collateral Pledge Agreement means any of the
following:

     Any investments allowed under the investment guidelines approved by the board of directors of
the Pledgor, provided that such investments shall meet the following limitations:

     Such investments shall be direct obligations of the United States of America or other
obligations the timely payment of the principal of and interest on which are fully and
unconditionally guaranteed by the United States of America or debt securities rated “A-” or better
by Standard & Poor’s Ratings Services or “Aa3” or better by Moody’s Investors Service, Inc,
provided that (i) no more than ten percent (10%) of the Collateral shall be invested at any time in
the obligations of any one corporate issuer, (ii) no such obligation shall have a maturity or
market expected average life in excess of seven (7) years, and (iii) such obligations shall not
have an average duration exceeding seven (7) years.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00169-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00169-of-00352.parquet"}]]